The U.S. drug firm, Eli Lilly & Co., reported Wednesday that an experimental medication might slow mild Alzheimer's if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a better treatment. (July 22)
Video provided by AP